Literature DB >> 15243108

Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital.

Jing-Jou Yan1, Wen-Chien Ko, Jiunn-Jong Wu, Shu-Huei Tsai, Chin-Luan Chuang.   

Abstract

In an epidemiologic and case-control study including 30 case patients over a 3.5-year period in a Taiwanese university hospital, only beta-lactamase inhibitor use and extended-spectrum cephalosporin use were identified as independent risk factors for nosocomial CMY-2-producing Escherichia coli bloodstream infection, and CMY-2 producers were found more prevalent than extended-spectrum beta-lactamase-producing isolates.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15243108      PMCID： PMC446286          DOI： 10.1128/JCM.42.7.3329-3332.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  14 in total

1.  Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals.

Authors:  Michèle Saladin; Van Thi Bao Cao; Thierry Lambert; Jean-Luc Donay; Jean-Louis Herrmann; Zahia Ould-Hocine; Charlotte Verdet; Françoise Delisle; Alain Philippon; Guillaume Arlet
Journal:  FEMS Microbiol Lett       Date:  2002-04-09       Impact factor: 2.742

2.  Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test.

Authors:  M T Nüesch-Inderbinen; H Hächler; F H Kayser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

Review 3.  Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics.

Authors:  A A Medeiros
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

4.  Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan.

Authors:  J J Yan; W C Ko; S H Tsai; H M Wu; Y T Jin; J J Wu
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans.

Authors:  P L Winokur; D L Vonstein; L J Hoffman; E K Uhlenhopp; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea.

Authors:  H Pai; S Lyu; J H Lee; J Kim; Y Kwon; J W Kim; K W Choe
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

8.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.

Authors:  E Lautenbach; J B Patel; W B Bilker; P H Edelstein; N O Fishman
Journal:  Clin Infect Dis       Date:  2001-03-26       Impact factor: 9.079

9.  Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes.

Authors:  J Versalovic; T Koeuth; J R Lupski
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

10.  Emergence of ceftriaxone-resistant Salmonella isolates and rapid spread of plasmid-encoded CMY-2-like cephalosporinase, Taiwan.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Cheng-Hsun Chiu; Shu-Huei Tsai; Hsiu-Mei Wu; Jiunn-Jong Wu
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
View more
  5 in total

1.  Cefotaxime for the detection of extended-spectrum β-lactamase or plasmid-mediated AmpC β-lactamase and clinical characteristics of cefotaxime-non-susceptible Escherichia coli and Klebsiella pneumoniae bacteraemia.

Authors:  Y Matsumura; M Yamamoto; A Matsushima; M Nagao; Y Ito; S Takakura; S Ichiyama
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-31       Impact factor: 3.267

2.  Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.

Authors:  Ju-Hsin Chia; Chishih Chu; Lin-Hui Su; Cheng-Hsun Chiu; An-Jing Kuo; Chien-Feng Sun; Tsu-Lan Wu
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

3.  Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007.

Authors:  J J Yan; J J Wu; C C Lee; W C Ko; F C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-11       Impact factor: 3.267

4.  High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center.

Authors:  Puneeta Tandon; Angela Delisle; Jeffrey E Topal; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-17       Impact factor: 11.382

Review 5.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.